No Role for Triple Antiplatelet Therapy?

被引：2

作者：

Antoniucci, David ^{[1
]}

机构：

[1] Careggi Hosp, Div Cardiol, I-50139 Florence, Italy

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2011年 / 57卷 / 03期

关键词：

cilostazol; DES; platelet reactivity; MAINTENANCE-DOSE CLOPIDOGREL; ELUTING STENT IMPLANTATION; OF-CARE ASSAY; PLATELET REACTIVITY; MYOCARDIAL-INFARCTION; CILOSTAZOL; INHIBITION; TRIAL; AGGREGATION; EVENTS;

D O I：

10.1016/j.jacc.2010.08.632

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：290 / 291

页数：2

共 50 条

[1] Comparison of On-Treatment Platelet Reactivity Between Triple Antiplatelet Therapy With Cilostazol and Standard Dual Antiplatelet Therapy in Patients Undergoing Coronary Interventions: A Meta-Analysis
Panchal, Hemang B.
Shah, Tejaskumar
Patel, Parthavkumar
Albalbissi, Kais
Molnar, Janos
Coffey, Brandon
Khosla, Sandeep
Ramu, Vijay
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 18 (06) : 533 - 543
[2] Triple versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Adding Cilostazol to Aspirin and Clopidogrel?
Niazi, Asfandyar K.
DiNicolantonio, James J.
Lavie, Carl J.
O'Keefe, James H.
Meier, Pascal
Bangalore, Sripal
CARDIOLOGY, 2013, 126 (04) : 233 - 243
[3] Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study
Kim, In-Suk
Jeong, Young-Hoon
Park, Yongwhi
Yoon, Seong-Eun
Kwon, Tae Jung
Park, Jeong Rang
Hwang, Seok-Jae
Koh, Eun-Ha
Kwak, Choong Hwan
Hwang, Jin-Yong
Kim, Sunjoo
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (04) : 629 - 640
[4] Antiplatelet Therapy After Percutaneous Coronary Intervention Should Another Regimen Be "TAPT?"
Croce, Kevin
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (01) : 3 - 5
[5] Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI
Yang, Tae-Hyun
Jin, Han-Young
Choi, Kyu-Nam
Do, Ungjeong
Kim, Hyung Jun
Chung, Sang-Ryul
Seo, Jeong-Sook
Jang, Jae-Sik
Kim, Dae-Kyeong
Kim, Dong-Soo
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) : 207 - 211
[6] The treatment of clopidogrel resistance: Triple antiplatelet therapy and future directions
Acikel, Sadik
Akdemir, Ramazan
Cagirci, Goksel
Yesilay, Asuman Bicer
Dogan, Mehmet
Kilic, Harun
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (01) : 79 - 82
[7] The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation
Shim, Chi Young
Yoon, Se-Jung
Park, Sungha
Kim, Jung-Sun
Choi, Jong Rak
Ko, Young-Guk
Choi, Donghoon
Ha, Jong-Won
Jang, Yangsoo
Chung, Namsik
Shim, Won-Heum
Cho, Seung-Yun
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 134 (03) : 351 - 355
[8] Efficacy and Safety of Triple Antiplatelet Therapy in Obese Patients Undergoing Stent Implantation
Gao, Wen
Zhang, Qinghua
Ge, Hailong
Guo, Yonghe
Zhou, Zhiming
ANGIOLOGY, 2013, 64 (07) : 554 - 558
[9] Is There a Need for "Triple Therapy"? Role of Anticoagulation with Dual Antiplatelet Therapy in Acute Coronary Syndromes (ATLAS Study & TRAP Study)
Patrick, William L.
Patel, Charmaine
Guddeti, Raviteja
Narayan, Aarti
Maddaleni, Michael
Kumar, Shankar
Dolma, Kalsang
Serla, Vishnu Vardhan
Sangha, Maheep
Govindavarjhulla, Aditya
Saddala, Prashanth
Singh, Priyamvada
Halaby, Rim
Gibson, C. Michael
CURRENT CARDIOLOGY REPORTS, 2013, 15 (10)
[10] Cilostazol-based triple antiplatelet therapy in the era of generic clopidogrel and new potent antiplatelet agents
Tselepis, Alexandros D.
CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (01) : 51 - 54

← 1 2 3 4 5 →